These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 16702955)

  • 1. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
    Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
    Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling.
    Chen F; Du Y; Zhang Z; Chen G; Zhang M; Shu HB; Zhai Z; Chen D
    Cell Signal; 2008 Apr; 20(4):666-74. PubMed ID: 18234474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
    Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
    J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF6 knockdown promotes survival and inhibits inflammatory response to lipopolysaccharides in rat primary renal proximal tubule cells.
    Liu S; Lutz J; Chang J; Liu D; Heemann U; Baumann M
    Acta Physiol (Oxf); 2010 Jul; 199(3):339-46. PubMed ID: 20136795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C.
    Byun HS; Park KA; Won M; Yang KJ; Shin S; Piao L; Kwak JY; Lee ZW; Park J; Seok JH; Liu ZG; Hur GM
    Mol Pharmacol; 2006 Sep; 70(3):1099-108. PubMed ID: 16798936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis.
    Kobayashi N; Kadono Y; Naito A; Matsumoto K; Yamamoto T; Tanaka S; Inoue J
    EMBO J; 2001 Mar; 20(6):1271-80. PubMed ID: 11250893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
    Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-kappaB.
    Muroi M; Tanamoto K
    J Leukoc Biol; 2008 Mar; 83(3):702-7. PubMed ID: 18070982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
    Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
    Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation.
    Wu GJ; Chen TL; Ueng YF; Chen RM
    Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
    Funakoshi-Tago M; Kamada N; Shimizu T; Hashiguchi Y; Tago K; Sonoda Y; Kasahara T
    Cytokine; 2009 Feb; 45(2):72-9. PubMed ID: 19091594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK).
    Yanagisawa K; Tago K; Hayakawa M; Ohki M; Iwahana H; Tominaga S
    Biochem J; 2003 Feb; 370(Pt 1):159-66. PubMed ID: 12418963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
    Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
    Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct molecular mechanism for initiating TRAF6 signalling.
    Ye H; Arron JR; Lamothe B; Cirilli M; Kobayashi T; Shevde NK; Segal D; Dzivenu OK; Vologodskaia M; Yim M; Du K; Singh S; Pike JW; Darnay BG; Choi Y; Wu H
    Nature; 2002 Jul; 418(6896):443-7. PubMed ID: 12140561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation.
    Ahmad R; Sylvester J; Zafarullah M
    Cell Signal; 2007 Dec; 19(12):2549-57. PubMed ID: 17905570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.